Outcomes
ADVERSE EVENTS, SECONDARY
The primary outcomes were (1) male partners testing and enrolling at the study clinic and (2) male partners initiated on PrEP or ART, evaluated through 12 months post‐partum. The secondary outcome was maternal VS at 12 months post‐partum. Serious adverse events related to PrEP were clinically monitored and reported in accordance with local guidelines.